Results 111 to 120 of about 2,895 (208)

Doença Mineral e Óssea (DMO) num Transplantado Renal [PDF]

, 2014
A 50-year-old post-menopausal recipient of a kidney allograft with bone pain, osteoporosis, persistent hypercalcaemia and elevated parathormone (PTH) levels, despite a satisfactory graft function, was treated with bisphosphonates and cinacalcet starting,
Adragão, T, Birne, R, Branco, P, Bruges, M, Casqueiro, A, Dickson, J, Ferreira, A, Jorge, C, Machado, D, Martins, AR, Matias, P, Oliveira, R, Silva, R, Torres, J, Weigert, A   +14 more
core  

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide

International Journal of Nephrology and Renovascular Disease, 2016
Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine Buemi, Michele Buemi Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy Abstract: Chronic kidney disease-mineral bone ...
Cernaro V, Santoro D, Lacquaniti A, Costantino G, Visconti L, Buemi A, Buemi M   +6 more
doaj  

Vascular calcification: pathogenesis, epidemiology anda clinical impact [PDF]

, 2010
Several studies suggest that vascular calcifications play a main role in the cardiovascular disease, which is one of the main causes of mortality in CKD patients.
Cabezas, Iván, Cannata, J.B. (Jorge), Díaz, J.B. (J.), López, Susana, Rodríguez, Minerva, Román-García, Pablo   +5 more
core  

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease

Therapeutics and Clinical Risk Management, 2021
Agnieszka Makowka, Michal Nowicki Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Lodz, PolandCorrespondence: Michal NowickiDepartment of Nephrology, Hypertension and Kidney Transplantation, Medical ...
Makowka A, Nowicki M
doaj  

Sevelamer 'carbonate': what's in a name? [PDF]

Nephrology Dialysis Transplantation, 2010
Clive, Harland, Oliver, Wrong
openaire   +2 more sources

Metastatic pulmonary calcification [PDF]

, 2016
Metastatic pulmonary calcification (MPC) may develop in patients with secondary hyperparathyroidism, related to end-stage renal disease (ESRD).1 The histologic pulmonary findings show calcium deposition in the lung interstitium, alveolar septa and ...
Baskin, Mark Harold, Peungjesada, Silanath, Winer-Muram, Helen T.   +2 more
core  

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate

Therapeutics and Clinical Risk Management, 2008
Ismail A Mohammed, Alastair J HutchisonManchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Oxford Road, Manchester, UKAbstract: Hyperphosphatemia is an inevitable consequence of end stage chronic kidney disease and is ...
Ismail A Mohammed, Alastair J Hutchison
doaj  

Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease

Therapeutics and Clinical Risk Management, 2020
Valeria Cernaro, Sebastiano Calimeri, Alfredo Laudani, Domenico Santoro Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, University of Messina, Messina, ItalyCorrespondence: Valeria CernaroUnit of Nephrology and Dialysis,
Cernaro V, Calimeri S, Laudani A, Santoro D   +3 more
doaj  

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients. [PDF]

Nephrol Dial Transplant, 2019
Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V, Walpen S, Floege J.   +7 more
europepmc   +1 more source

Calcifilaxia: Revisão da Literatura a Propósito de 2 Casos Clínicos [PDF]

, 2014
Calciphylaxis is a rare and devastating obliterative vasculopathy, leading to ischemia and subcutaneous necrosis. In most cases it affects patients with renal disease and is associated with high morbidity and mortality.
Ferreira, A, Ferreira, AC, Mendes, M, Nolasco, F   +3 more
core